Elit LM - Search Results

1

Patients' preferences for therapy in advanced epithelial ovarian cancer: development, testing, and application of a bedside decision instrument.

Elit LM, Levine MN, Gafni A, Whelan TJ, Doig G, Streiner DL, Rosen B. Elit LM, et al. Gynecol Oncol. 1996 Sep;62(3):329-35. doi: 10.1006/gyno.1996.0244. Gynecol Oncol. 1996. PMID: 8812525

2

Economic and policy implications of adopting paclitaxel as first-line therapy for advanced ovarian cancer: an Ontario perspective.

Elit LM, Gafni A, Levine MN. Elit LM, et al. J Clin Oncol. 1997 Feb;15(2):632-9. doi: 10.1200/JCO.1997.15.2.632. J Clin Oncol. 1997. PMID: 9053487

3

A comparison of two prophylactic regimens for hypersensitivity reactions to paclitaxel.

Kwon JS, Elit L, Finn M, Hirte H, Mazurka J, Moens F, Trim K. Kwon JS, et al. Gynecol Oncol. 2002 Mar;84(3):420-5. doi: 10.1006/gyno.2001.6546. Gynecol Oncol. 2002. PMID: 11855881

4

Follow-up after primary therapy for endometrial cancer: a systematic review.

Fung-Kee-Fung M, Dodge J, Elit L, Lukka H, Chambers A, Oliver T; Cancer Care Ontario Program in Evidence-based Care Gynecology Cancer Disease Site Group. Fung-Kee-Fung M, et al. Gynecol Oncol. 2006 Jun;101(3):520-9. doi: 10.1016/j.ygyno.2006.02.011. Epub 2006 Mar 23. Gynecol Oncol. 2006. PMID: 16556457 Review.

5

Treating vulvar cancer in the new millennium: are patients receiving optimal care?

Barbera L, Thomas G, Elit L, Covens A, Fyles A, Osborne R, Yun L. Barbera L, et al. Gynecol Oncol. 2008 Apr;109(1):71-5. doi: 10.1016/j.ygyno.2007.12.015. Epub 2008 Jan 29. Gynecol Oncol. 2008. PMID: 18234304

6

Surgical outcomes in women with ovarian cancer.

Elit LM, Bondy SJ, Paszat LP, Holowaty EJ, Thomas GM, Stukel TA, Levine MN. Elit LM, et al. Can J Surg. 2008 Oct;51(5):346-54. Can J Surg. 2008. PMID: 18841223 Free PMC article.

7

Expectant management versus immediate treatment for low-grade cervical intraepithelial neoplasia : a randomized trial in Canada and Brazil.

Elit L, Levine MN, Julian JA, Sellors JW, Lytwyn A, Chong S, Mahony JB, Gu C, Finch T, Zeferino LC. Elit L, et al. Cancer. 2011 Apr 1;117(7):1438-45. doi: 10.1002/cncr.25635. Epub 2010 Nov 8. Cancer. 2011. PMID: 21425144 Free article. Clinical Trial.

8

Temporal trends in the relative survival among patients diagnosed with ovarian cancer in Canada 1992-2005: a population-based study.

Akhtar-Danesh N, Elit L, Lytwyn A. Akhtar-Danesh N, et al. Gynecol Oncol. 2011 Nov;123(2):192-5. doi: 10.1016/j.ygyno.2011.07.098. Epub 2011 Aug 19. Gynecol Oncol. 2011. PMID: 21855119

9

Walking a tightrope: oncologists' perspective on providing information to women with recurrent ovarian cancer (ROC) during the medical encounter.

Elit L, Charles C, Gafni A, Ranford J, Gold ST, Gold I. Elit L, et al. Support Care Cancer. 2012 Oct;20(10):2327-33. doi: 10.1007/s00520-011-1344-0. Epub 2011 Dec 14. Support Care Cancer. 2012. PMID: 22167296

10

Five-year trends in mortality indices among gynecological cancer patients in Canada.

Akhtar-Danesh N, Lytwyn A, Elit L. Akhtar-Danesh N, et al. Gynecol Oncol. 2012 Dec;127(3):620-4. doi: 10.1016/j.ygyno.2012.08.038. Epub 2012 Sep 1. Gynecol Oncol. 2012. PMID: 22943877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters